Dr Renee Bethea Thomas, MD | |
1905 Carriage House Ln, Camden, SC 29020-2752 | |
(803) 424-2304 | |
Not Available |
Full Name | Dr Renee Bethea Thomas |
---|---|
Gender | Female |
Speciality | |
Experience | Years |
Location | 1905 Carriage House Ln, Camden, South Carolina |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1568432128 | NPI | - | NPPES |
DD4130 | Other | SC | RAILROAD MEDICARE GROUP |
P00226494 | Other | SC | RAILROAD MEDICARE |
GP4159 | Other | SC | MEDICAID GROUP |
166750 | Medicaid | SC | |
8256 | Other | SC | MEDICARE GROUP |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207ZP0102X | Pathology - Anatomic Pathology & Clinical Pathology | 16675 (South Carolina) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Renee Bethea Thomas, MD 1905 Carriage House Ln, Camden, SC 29020-2752 Ph: (803) 424-2304 | Dr Renee Bethea Thomas, MD 1905 Carriage House Ln, Camden, SC 29020-2752 Ph: (803) 424-2304 |
News Archive
Accuray Incorporated, a global leader in the field of radiosurgery, announced today that 28 CyberKnife-focused abstracts have been accepted as part of the 51st Annual Meeting of the American Society for Radiation Oncology (ASTRO), taking place November 1 - 5 in Chicago, Illinois. This represents a 27 percent increase in CyberKnife abstracts over last year's Annual Meeting.
If you experience a major heart attack the damage could cost you around five billion heart cells. Future stem cell treatments will require this number and more to ensure those cells are replaced and improve your chances of survival.
Scientists funded by the Medical Research Council (MRC) and The Stroke Association have found that surgery can halve the risk of a stroke for people who have significant narrowing of the main artery carrying blood to the brain. Their findings, published in this week's The Lancet, are the result of a large-scale international clinical trial.
Analysis of the largest American cancer database indicates that racial disparities persist in the treatment and outcomes of patients diagnosed with stage I non-small cell lung cancer (NSCLC).
› Verified 4 days ago